Overview
Nobuhiro Shimozawa practices in Tsukuba, Japan. Shimozawa is rated as an Experienced expert by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Their top areas of expertise are Retinopathy Pigmentary Mental Retardation, CLN1 Disease, CLN4 Disease, and CLN3 Disease.
Their clinical research consists of co-authoring 23 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Age-Related Macular Degeneration (ARMD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Age-Related Macular Degeneration (ARMD)
- Alzheimer's DiseaseShimozawa isExperienced. Learn about Alzheimer's Disease.
- Batten DiseaseShimozawa isExperienced. Learn about Batten Disease.
- CLN1 DiseaseShimozawa isExperienced. Learn about CLN1 Disease.
- CLN2 DiseaseShimozawa isExperienced. Learn about CLN2 Disease.
- CLN3 DiseaseShimozawa isExperienced. Learn about CLN3 Disease.